title: A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature.
abstract: Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.
authors.affiliation: Department of Psychiatry, Sheba Medical Center, and Sackler School of Medicine, Tel Aviv University , Tel Hashomer, Israel. Electronic address: jzohar@post.tau.ac.il.
authors.forename: Joseph
authors.initials: J
authors.lastname: Zohar
authors.affiliation: Department of Psychiatry, University of California, San Diego, USA.
authors.forename: Stephen
authors.initials: S
authors.lastname: Stahl
authors.affiliation: Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany.
authors.forename: Hans-Jurgen
authors.initials: HJ
authors.lastname: Moller
authors.affiliation: Department of Psychiatry and Cellular & Molecular Medicine, University of Ottawa, Canada K1Z 7K4.
authors.forename: Pierre
authors.initials: P
authors.lastname: Blier
authors.affiliation: Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
authors.forename: David
authors.initials: D
authors.lastname: Kupfer
authors.affiliation: Department of Psychiatry and Neurosciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
authors.forename: Shigeto
authors.initials: S
authors.lastname: Yamawaki
authors.affiliation: Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Uchida
authors.affiliation: Spedding Research Solutions SARL, 6 Rue Ampere, Le Vesinet 78110, France.
authors.forename: Michael
authors.initials: M
authors.lastname: Spedding
authors.affiliation: University Department, Warneford Hospital, Oxford OX3 7JX , UK.
authors.forename: Guy M
authors.initials: GM
authors.lastname: Goodwin
authors.affiliation: Centre for Neuropsychopharmacology Division of Brain Sciences Imperial College, London, UK.
authors.forename: David
authors.initials: D
authors.lastname: Nutt
mesh_terms: D006801:Humans; D009488:Neurosciences; D011619:Psychotropic Drugs / Q000145:classification / Q000627:therapeutic use; D009626:Terminology as Topic
chemical_list: D011619:Psychotropic Drugs
keywords: Adherence; Mode of action; Neuroscience; Nomenclature; Pharmacological domain; Psychotropic drugs